Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis
Li Xin Zhang(Montreal Heart Institute), Matthieu Pelletier‐Galarneau(Montreal Heart Institute), Geneviève Giraldeau(Montreal Heart Institute), Marie-Claude Parent(Montreal Heart Institute), François Harel(Montreal Heart Institute), Patrick Martineau(BC Cancer Agency), Vincent Finnerty(Montreal Heart Institute)
Cited by 24
Related Papers
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
|Canadian Journal of Cardiology|2021|290
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
|Canadian Journal of Cardiology|2020|121
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
|Canadian Journal of Cardiology|2020|112
Improved Function and Myocardial Repair of Infarcted Heart by Intracoronary Injection of Mesenchymal Stem Cell-Derived Growth Factors
|Journal of Cardiovascular Translational Research|2010|109
Care Gaps in Adherence to Heart Failure Guidelines
|JACC Heart Failure|2020|104